AGO2 and metabolic dysfunction-associated steatohepatitis: Of note, miR-122 had the most remarkable changes, with its primarily Ago2-free levels being 7.2-fold higher in NASH vs. healthy controls and 3.1-fold higher in NASH vs. steatosis.